Biofeedback — CPB 0132 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0132 governing biofeedback coverage, effective September 26, 2025. Here's what billing teams need to know before submitting claims.

The updated Aetna biofeedback coverage policy under CPB 0132 Aetna system clarifies medical necessity criteria across ten covered indications and expands its list of experimental, investigational, or unproven designations. The primary billing codes affected are CPT 90901, 90912, +90913, 90875, and 90876. If your practice bills biofeedback for any condition — pelvic floor dysfunction, headache, neuromuscular rehab, or anything else — this coverage policy change deserves your attention before you submit another claim.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Biofeedback — CPB 0132
Policy Code	CPB 0132
Change Type	Modified
Effective Date	September 26, 2025
Impact Level	High
Specialties Affected	Gastroenterology, Urology, Neurology, Physical Medicine & Rehabilitation, Behavioral Health, Pain Management, Physical Therapy
Key Action	Audit all biofeedback claims against the ten covered indications and update your charge capture to flag non-covered diagnoses before billing

---

Aetna Biofeedback Coverage Criteria and Medical Necessity Requirements 2025

Aetna considers biofeedback medically necessary for exactly ten conditions. That list is not a suggestion — it's a hard boundary. If your ICD-10 diagnosis code doesn't map to one of these indications, expect a claim denial.

The ten covered indications under the updated CPB 0132 Aetna coverage policy are:

A few of these have conditions attached. Chronic constipation requires anorectal manometry confirmation before biofeedback is covered. Bill CPT 91122 alongside CPT 90912 when billing for that indication, and make sure the manometry result is in the documentation before you submit.

Headache coverage has a specific carve-out. EMG, skin, and thermal biofeedback for migraine and tension headaches are covered. EEG biofeedback — also called neurofeedback — is not. Aetna explicitly calls EEG biofeedback experimental, investigational, or unproven for headache. Billing CPT 90901 with a headache diagnosis and an EEG-based modality is a direct path to denial.

For neuromuscular rehabilitation of stroke and TBI, the AutoMove AM800 device is specifically excluded. Aetna classifies it as a neuromuscular electrical stimulator under CPB 0677, not biofeedback. Billing it as biofeedback won't fly — and the policy says the evidence doesn't support it either.

On medical necessity more broadly: Aetna does not consider biofeedback medically necessary when used to improve emotional or physical health in non-diseased persons. Wellness applications, stress reduction, and performance optimization don't qualify. That's not a gray area. The policy language is direct.

The updated policy does not spell out prior authorization requirements within the CPB 0132 document itself. Check your specific plan contracts and Aetna's authorization lookup tool for prior authorization requirements on CPT 90875, 90876, and 90901. High-volume biofeedback billing for conditions like urinary incontinence or neuromuscular stroke rehab is exactly the kind of utilization that triggers pre-auth requirements at the plan level, even when the CPB is silent.

---

Aetna Biofeedback Exclusions and Non-Covered Indications

This is where the policy gets detailed — and where most billing teams get into trouble. The experimental, investigational, or unproven list in CPB 0132 is long. Don't treat it as background noise.

Specific devices and approaches that are not covered:

That last one matters enormously. Biofeedback delivered at home is not covered under this policy, regardless of the diagnosis. If your practice is issuing biofeedback devices for home use or billing home-based sessions, you have a reimbursement problem. Review those claims now.

Conditions for which biofeedback is not covered (partial list):

The policy lists a substantial number of non-covered conditions. Here are the ones most likely to affect billing teams:

Chronic pain is a particularly high-risk area. Biofeedback for back pain, fibromyalgia, and neck pain is explicitly non-covered. These are common referral diagnoses for biofeedback. If your billing team is submitting CPT 90901 against ICD-10 codes like M54.5 (low back pain) or M79.3 (panniculitis), you're billing against policy.

The real issue here is that some of these exclusions sit adjacent to covered indications. Urinary incontinence is covered. Neurogenic bladder is not. Non-neuropathic voiding disorders are not. Daytime urinary frequency is not. If your documenting clinician codes loosely or uses a broader diagnosis code, claims will deny. Documentation specificity is everything.

---

Coverage Indications at a Glance

---

Aetna Biofeedback Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. If you haven't reviewed your biofeedback charge capture against this policy, do it now.

Copy Action Items

If your biofeedback billing guidelines haven't been updated since last year, use this policy revision as the trigger to do a full audit. The list of non-covered conditions is long enough that it's worth having your compliance officer or billing consultant walk through your top diagnosis codes against the CPB 0132 criteria before September 26, 2025.

---

CPT, HCPCS, and ICD-10 Codes for Biofeedback Under CPB 0132

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered / Experimental HCPCS Codes

Code	Type	Description	Reason Copy
E0746	HCPCS	Electromyography (EMG) biofeedback device	Not covered for indications listed in CPB 0132
E3200	HCPCS	Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components	Not covered — InTandem/rhythmic auditory stimulation listed as experimental

Key ICD-10-CM Diagnosis Code Ranges Referenced in CPB 0132

The full policy references 814 ICD-10-CM codes. The ranges below represent the diagnostic categories in the policy. Most appear in the policy as documentation of non-covered or experimental indications — not as covered diagnoses. Always map the diagnosis to the covered indication list above before billing.

The full ICD-10 code list in CPB 0132 spans 814 codes. Review the complete policy at app.payerpolicy.org/p/aetna/0132 for the unabridged list.

---